{"id":37574,"topic":"peptides","source":"搜狐网","title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","url":"https://www.sohu.com/a/1049305805_120988533","url_hash":"f4d7c46429ae46210657b1e1e5ed1592768d4c34","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1lMlJsX2dMOGtQLWlOVVlFeHZ6RVlNb3VoSDB0OU93cWp5cERvTHlzbVV0WWFwQkxDYkdUT3lla0RPUzlaU3llR2twY3lCYkZJTENKZVpn?oc=5\" target=\"_blank\">圣诺生物：预计2026年上半年净利同比增长43.23%-64.79%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">搜狐网</font>","content":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一步增强公司在多肽医药市场的全球化竞争力。\n指标注解：\n市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。\n市净率=总市值/净资产。市净率估值法多用于盈利波动较大而净资产相对稳定的公司。\n市销率=总市值/营业收入。市销率估值法通常用于亏损或微利的成长型公司。\n文中市盈率和市销率采用TTM方式，即以截至最近一期财报（含预报）12个月的数据计算。市净率采用LF方式，即以最近一期财报数据计算。三者的分位数计算区间均为公司上市以来至最新公告日。\n市盈率、市净率为负时，不显示当期分位数，会导致折线图中断。","image_url":"//q5.itc.cn/q_70/images03/20260712/0994a669f53f4f6c8598a342d80b2d80.png","lang":"zh","published_at":"2026-07-12T09:42:42+00:00","fetched_at":"2026-07-15T16:15:14+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","cluster_id":1718465,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.sohu.com/a/1049305805_120988533","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}},"news_item":{"id":37574,"canonical_url":"https://www.sohu.com/a/1049305805_120988533","source_url":"https://www.sohu.com/a/1049305805_120988533","title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","source_name":"搜狐网","author":null,"published_at":"2026-07-12T09:42:42+00:00","locale":"zh","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMiVkFVX3lxTE1lMlJsX2dMOGtQLWlOVVlFeHZ6RVlNb3VoSDB0OU93cWp5cERvTHlzbVV0WWFwQkxDYkdUT3lla0RPUzlaU3llR2twY3lCYkZJTENKZVpn?oc=5\" target=\"_blank\">圣诺生物：预计2026年上半年净利同比增长43.23%-64.79%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">搜狐网</font>","full_text":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一步增强公司在多肽医药市场的全球化竞争力。\n指标注解：\n市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。\n市净率=总市值/净资产。市净率估值法多用于盈利波动较大而净资产相对稳定的公司。\n市销率=总市值/营业收入。市销率估值法通常用于亏损或微利的成长型公司。\n文中市盈率和市销率采用TTM方式，即以截至最近一期财报（含预报）12个月的数据计算。市净率采用LF方式，即以最近一期财报数据计算。三者的分位数计算区间均为公司上市以来至最新公告日。\n市盈率、市净率为负时，不显示当期分位数，会导致折线图中断。","excerpt":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 497 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","url":"https://www.sohu.com/a/1049305805_120988533","summary":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","source":"搜狐网","date":"2026-07-12T09:42:42+00:00","content":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一步增强公司在多肽医药市场的全球化竞争力。\n指标注解：\n市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。\n市净率=总市值/净资产。市净率估值法多用于盈利波动较大而净资产相对稳定的公司。\n市销率=总市值/营业收入。市销率估值法通常用于亏损或微利的成长型公司。\n文中市盈率和市销率采用TTM方式，即以截至最近一期财报（含预报）12个月的数据计算。市净率采用LF方式，即以最近一期财报数据计算。三者的分位数计算区间均为公司上市以来至最新公告日。\n市盈率、市净率为负时，不显示当期分位数，会导致折线图中断。","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 497 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/37574","export_markdown":"/api/items/37574/export?format=markdown","export_json":"/api/items/37574/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533"},"formats":{"full":{"id":37574,"title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","url":"https://www.sohu.com/a/1049305805_120988533","source":"搜狐网","author":null,"published_at":"2026-07-12T09:42:42+00:00","locale":"zh","topic":"peptides","tags":[],"excerpt":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","full_text":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一步增强公司在多肽医药市场的全球化竞争力。\n指标注解：\n市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。\n市净率=总市值/净资产。市净率估值法多用于盈利波动较大而净资产相对稳定的公司。\n市销率=总市值/营业收入。市销率估值法通常用于亏损或微利的成长型公司。\n文中市盈率和市销率采用TTM方式，即以截至最近一期财报（含预报）12个月的数据计算。市净率采用LF方式，即以最近一期财报数据计算。三者的分位数计算区间均为公司上市以来至最新公告日。\n市盈率、市净率为负时，不显示当期分位数，会导致折线图中断。","reading_time_min":1,"extraction":{"state":"ok","confidence":0.9,"error":null,"explanation":"High confidence: full text extraction produced 497 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}},"actions":{"read":"/item/37574","export_markdown":"/api/items/37574/export?format=markdown","export_json":"/api/items/37574/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533"}},"digest":{"id":37574,"title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","url":"https://www.sohu.com/a/1049305805_120988533","source":"搜狐网","topic":"peptides","published_at":"2026-07-12T09:42:42+00:00","excerpt":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。 据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","quality_bucket":"high","quality_reason":"High confidence: full text extraction produced 497 characters.","reading_time_min":1,"cluster_id":1718465},"card":{"display_title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","subtitle":"搜狐网 · 2026-07-12","summary":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。…","badges":["quality:high"],"links":{"read":"/item/37574","original":"https://www.sohu.com/a/1049305805_120988533","diagnose":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533"},"quality_warning":null},"export":{"title":"圣诺生物：预计2026年上半年净利同比增长43.23%-64.79% - 搜狐网","url":"https://www.sohu.com/a/1049305805_120988533","summary":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一…","source":"搜狐网","date":"2026-07-12T09:42:42+00:00","content":"以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示：\n资料显示，公司主营多肽创新药CDMO服务、多肽原料药、多肽制剂产品、多肽类产品定制生产服务、多肽药物生产技术转让服务。\n据公告，报告期内，公司紧密围绕年度经营目标，积极布局主营业务，持续拓展国内外市场。在此驱动下，公司多肽原料药业务呈持续增长趋势，带动公司整体业绩稳步提升；其次，得益于公司新建产能的逐步释放，规模化生产效应与生产工艺持续优化，有效提升公司整体盈利能力，进一步增强公司在多肽医药市场的全球化竞争力。\n指标注解：\n市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。\n市净率=总市值/净资产。市净率估值法多用于盈利波动较大而净资产相对稳定的公司。\n市销率=总市值/营业收入。市销率估值法通常用于亏损或微利的成长型公司。\n文中市盈率和市销率采用TTM方式，即以截至最近一期财报（含预报）12个月的数据计算。市净率采用LF方式，即以最近一期财报数据计算。三者的分位数计算区间均为公司上市以来至最新公告日。\n市盈率、市净率为负时，不显示当期分位数，会导致折线图中断。","confidence":0.9,"diagnostics_url":"/api/diagnose?url=https%3A//www.sohu.com/a/1049305805_120988533","quality_bucket":"high","failure_kind":"none","retryable":false,"quality_reason":"High confidence: full text extraction produced 497 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"high","confidence":0.9,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"High confidence: full text extraction produced 497 characters.","operator_guidance":{"severity":"ok","recommended_action":"trust_full_text","next_step":"Use the extracted full text as the primary article source.","operator_label":"Ready","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"full_text","label":"Full text","has_full_text":true,"has_summary":true,"content_length":497,"summary_length":221,"usable_text_length":497,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":497,"summary_length":221}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}